Acomust-300 SR Tablet

Acotiamide 300 mg Sustained Release Tablets — Once-Daily Prokinetic (DCGI Approved)

Acomust-300 SR Tablet — Acotiamide 300 mg (Sustained Release) — DCGI Approved Molecule from Trumac Healthcare PCD Pharma Franchise India

Composition Acotiamide 300 mg (Sustained Release) — DCGI Approved Molecule
Dosage Form Sustained Release Tablet
Pack Type Alu-Alu Blister
Pack Size 10 x 1 x 10 Tablets
MRP ₹ 4900
Therapy G.P. + Gastroenterology — Prokinetic / Acetylcholinesterase Inhibitor (SR)
Storage Store below 30 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Acomust-300 SR Tablet

Acomust-300 SR Tablet is a sustained-release formulation of Acotiamide 300 mg from Trumac Healthcare — a DCGI-approved once-daily prokinetic for the management of functional dyspepsia. The SR matrix releases acotiamide gradually over the dosing interval, maintaining therapeutic plasma concentrations with a single daily dose, improving adherence over the conventional thrice-daily regimen.

Acotiamide acts peripherally on the enteric nervous system by inhibiting acetylcholinesterase and antagonising pre-synaptic muscarinic M1/M2 autoreceptors, enhancing acetylcholine release at the myenteric plexus. The result is improved gastric accommodation, faster gastric emptying and relief from early satiety, postprandial fullness and epigastric burning — the hallmark symptoms of postprandial distress syndrome.

Acomust-300 SR is manufactured in WHO-GMP certified facilities and is positioned as a premium, high-margin SKU for any gastroenterology franchise. The DCGI-approved status supports prescription credibility with gastroenterologists and general physicians.

Indications

  • Functional dyspepsia — postprandial-distress and epigastric-pain subtypes
  • Early satiety; postprandial fullness; chronic upper-abdominal bloating
  • Non-erosive reflux disease with motility component
  • Adjunct in mild diabetic gastroparesis

Mechanism of Action

Acotiamide produces dual peripheral cholinergic enhancement: it inhibits acetylcholinesterase in the upper GI tract and blocks pre-synaptic muscarinic M1 and M2 autoreceptors. Together these actions raise acetylcholine availability at the myenteric plexus, improving gastric accommodation and antral motility without central dopaminergic effects.

Dosage & Administration

Adults: one Acomust-300 SR tablet once daily, before a meal, for 4 weeks. Re-evaluate after 4 weeks. To be prescribed by a physician. Swallow whole; do not crush or chew.

Side Effects

Diarrhoea, constipation, nausea, headache, mild abdominal discomfort. Rare: hepatic enzyme elevation, hypersensitivity reactions.

Contraindications & Precautions

Hypersensitivity to acotiamide. Use with caution in hepatic impairment. Not recommended in children, pregnancy or lactation unless specifically advised by a physician. Do not crush or break the SR tablet.

Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Acomust-300 SR Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Acomust-300 SR Tablet used for?

Acomust-300 SR Tablet contains Acotiamide 300 mg in a sustained-release form and is used for functional dyspepsia — particularly postprandial-distress syndrome with early satiety, fullness and bloating.

Is Acomust-300 a DCGI-approved molecule?

Yes, Acotiamide is a DCGI-approved molecule. Acomust-300 SR is Trumac's once-daily sustained-release formulation, manufactured under WHO-GMP conditions.

Why a once-daily SR formulation?

The sustained-release matrix maintains therapeutic plasma levels of acotiamide over 24 hours, replacing the conventional thrice-daily regimen and significantly improving patient adherence.

Is Acomust-300 SR available for PCD pharma franchise?

Yes, Trumac Healthcare offers Acomust-300 SR on monopoly-based PCD pharma franchise as a premium gastroenterology SKU, and for third-party manufacturing.

How should Acomust-300 SR be stored?

Store below 30 °C in a dry place, away from direct sunlight and moisture. Swallow the tablet whole; do not crush or chew.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.